leadf
logo-loader

Medical technology & services

Add to MyProactive
Health

CardieX halted ahead of material commercialisation agreement...

The securities will remain in a trading halt until Thursday, September 24 or when an announcement is...

Emma Davies

14.02 Tue 22 Sep 2020

SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals anagrelide oral spray formulation supported by new study results Health SUDA Pharmaceuticals anagrelide oral spray formulation supported...
20 hours, 48 minutes ago
Cardiex Ltd - Cardiex subsidiary granted European patent for its unique SphygmoCor blood pressure technology Health CardieX subsidiary granted European patent for unique SphygmoCor...
4 days, 16 hours ago
Atomo Diagnostics with Proactive at the ASX Small and Mid-Cap Conference 2020 Health Atomo Diagnostics with Proactive at the ASX Small and Mid-Cap...
1 week, 6 days ago
CardieX Limited signs disruptive deal with Chinese medical device company Andon Health CardieX Limited signs disruptive deal with Chinese medical device...
2 weeks ago
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals secures Australia patent for Anagrelide cancer treatment
2 weeks, 1 day ago
Cardiex Ltd - Cardiex subsidiary partners with Andon to manufacture telehealth and remote patient home health monitoring devices
2 weeks, 2 days ago
Cardiex Ltd - CardieX subsidiary ATCOR enters into new amended agreement with global pharmaceutical company Bayer AG
on 20/8/20
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals appoints Phillip Hains as company secretary effective from July
on 18/8/20
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals chairman demonstrates faith in the company’s pharmaceutical strategy by participating in entitlement offer
on 7/8/20
SUDA Pharmaceuticals Ltd - completes entitlement offer to raise $3.56 million
on 5/8/20
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals closes oversubscribed entitlement offer to raise $3.56 million
on 3/8/20
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals' Dr Michael Baker hails regulatory approval for lead product ZolpiMist
on 31/7/20
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals on the prowl for new technologies and products to add to its current programs
on 30/7/20
SUDA Pharmaceuticals Ltd - SUDA Pharmaceuticals receives TGA approval for the registration of ZolipMist™
on 29/7/20
CardieX completes capital raise while also providing insight on the growth in the MedTech Industry
on 28/7/20
Cardiex Ltd - Cardiex completes $2.5 million placement from new strategic investors
on 27/7/20
Cardiex Ltd - CardieX in trading halt regarding capital raising activity
on 23/7/20
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals CEO outlines plans going forward in letter to shareholders
on 16/7/20
SUDA Pharmaceuticals Ltd - Suda Pharmaceuticals gets coverage from Edison with 13 cents per share valuation
on 8/7/20